GlassScriptPhysician profile
James L Womack
NPI 1275755530
$46,142.66
in general payments reported to CMS, 2019-2025
11 companies · $8,825 in 2025
The $8,825 reported for 2025 was more than what 86% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,692 · 2020: $3,047 · 2021: $725 · 2022: $14K · 2023: $9,746 · 2024: $3,851 · 2025: $8,825.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $18K · Food and Beverage: $4,054 · Education: $234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $18,132.79 |
| Food and Beverage | $4,054.40 |
| Education | $233.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Think Surgical, INC. | $33,877.68 | 2021-2025 | |
| Encore Medical, LP | $7,016.21 | 2019-2025 | Djo Surgical |
| Zimmer Biomet Holdings, INC. | $1,755.78 | 2019-2025 | Oxford, Oxford Partial Knee, Znn |
| Stryker Corporation | $1,745.61 | 2019-2025 | Pangea, Mako, Variax |
| Linvatec Corporation | $1,276.58 | 2019-2024 | Biobrace 23mm |
| Titan Surgical Group, LLC | $167.06 | 2023-2025 | |
| Kinamed, INC. | $148.92 | 2023 | |
| Heron Therapeutics, INC. | $80.47 | 2025 | Zynrelef |
| Medacta USA, INC. | $35.89 | 2025 | Gmk Revision |
| Integra Lifesciences Corporation | $25.42 | 2020 | |
| Pacira Therapeutics, INC. | $13.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Womack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.